Nimocal®
NimodipineCalcium Antagonists (Cardiovascular Preparations) Indication: For the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition. Dosage & Administration: Initial dose is 60 mg in every four hours interval for 21 consecutive days. Oral therapy […]